Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors

NCT00594633 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Brain Tumor
Brain Cancer
Cns Cancer
Cognitive Dysfunction

Interventions

OTHER: donepezil and questionaires

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]